Semi-lunar valve development

pathway activity — cross-omics
GO:1905314Cross-omicsPROTEIN-MS → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Semi-lunar valve development pathway is significantly associated with the protein abundance of multiple proteins, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are AGR2, CDH11, and SLCO4C1_S16, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Semi-lunar valve development activity versus AGR2 in HNSC (Pearson r = -0.27).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCAGR2 →-0.840-0.591.003.00134
BRCACDH11 →+0.703+0.986<.001<.00134
LSCCSLCO4C1_S16 →-1.122-1.047<.001<.00133
LUADTFF3 →-1.853-0.590<.001<.00133
GBMISCA2 →-0.233-0.827<.001<.00133
LSCCRB1_S795 →+0.963+0.660.003.00533
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1905314 vs AGR2 — HNSC

Per-sample scatter of Semi-lunar valve development activity vs AGR2 in HNSC.

Explore this scatter interactively →

Exploration